Vivus resubmitted its new drug application for Qnexa in October with a contraindication for women of childbearing age, and is studying the impact of the drug in pregnant women and babies.

FORBES: Vivus Data Shows Weight Loss Drug Ingredient Associated with Oral Clefts

Boehringer Ingelheim is starting to inform physicians about a new contraindication for its oral anticoagulant drug Pradaxa (dabigatran).

FORBES: Pradaxa To Be Contraindicated In Patients With Mechanical Heart Valves